ATE532517T1 - Thioridazin und seine derivate zur umkehr von antimikrobieller arzneimittelresistenz - Google Patents

Thioridazin und seine derivate zur umkehr von antimikrobieller arzneimittelresistenz

Info

Publication number
ATE532517T1
ATE532517T1 AT04798860T AT04798860T ATE532517T1 AT E532517 T1 ATE532517 T1 AT E532517T1 AT 04798860 T AT04798860 T AT 04798860T AT 04798860 T AT04798860 T AT 04798860T AT E532517 T1 ATE532517 T1 AT E532517T1
Authority
AT
Austria
Prior art keywords
thioridazine
antibacterials
derivatives
reverting
drug resistance
Prior art date
Application number
AT04798860T
Other languages
English (en)
Inventor
Jorn Christensen
Oliver Hendricks
Jette Kristiansen
Original Assignee
Noa Sic Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noa Sic Aps filed Critical Noa Sic Aps
Application granted granted Critical
Publication of ATE532517T1 publication Critical patent/ATE532517T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT04798860T 2003-11-13 2004-11-15 Thioridazin und seine derivate zur umkehr von antimikrobieller arzneimittelresistenz ATE532517T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301690 2003-11-13
PCT/IB2004/003730 WO2005046694A1 (en) 2003-11-13 2004-11-15 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance

Publications (1)

Publication Number Publication Date
ATE532517T1 true ATE532517T1 (de) 2011-11-15

Family

ID=34585771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04798860T ATE532517T1 (de) 2003-11-13 2004-11-15 Thioridazin und seine derivate zur umkehr von antimikrobieller arzneimittelresistenz

Country Status (6)

Country Link
US (1) US8623864B2 (de)
EP (1) EP1689405B1 (de)
AT (1) ATE532517T1 (de)
DK (1) DK1689405T3 (de)
ES (1) ES2377016T3 (de)
WO (1) WO2005046694A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689405B1 (de) 2003-11-13 2011-11-09 Noa Sic Aps Thioridazin und seine derivate zur umkehr von antimikrobieller arzneimittelresistenz
DK1744781T3 (da) * 2004-04-30 2012-10-15 Bkg Pharma Aps Behandling af infektionssygdomme
EP2246349A1 (de) * 2009-04-20 2010-11-03 BKG Pharma ApS Behandlung von Infektionskrankheiten
US20160120876A1 (en) * 2014-04-28 2016-05-05 Chi-Ying Huang Pharmaceutical composition for treatment of cancer using phenothiazine
US9198916B1 (en) 2014-05-27 2015-12-01 B&G Partners, Llc Compounds and methods for treating tumors
WO2017212239A1 (en) * 2016-06-07 2017-12-14 Novabiotics Limited Treatment of drug-resistant microbial infections
WO2018070874A1 (en) * 2016-10-12 2018-04-19 Rijksuniversiteit Groningen Means and methods for reducing or avoiding antibiotic resistance and spread of virulence in human pathogens

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL105360C (de) 1957-07-31
FR2813792B1 (fr) 2000-09-12 2003-03-14 Inst Necker Moyens pour la regulation des defenses immunitaires
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
EP1360180A1 (de) 2001-01-19 2003-11-12 Cytokinetics, Inc. Phenothiazinkinesininhibitoren
WO2002089810A1 (en) 2001-05-07 2002-11-14 United States Army Medical Research And Materiel Command Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
US20030229082A1 (en) 2002-01-16 2003-12-11 The Regents Of The University Of California Inhibition of RNA function
EP1689405B1 (de) 2003-11-13 2011-11-09 Noa Sic Aps Thioridazin und seine derivate zur umkehr von antimikrobieller arzneimittelresistenz

Also Published As

Publication number Publication date
US20070287702A1 (en) 2007-12-13
DK1689405T3 (da) 2012-02-20
EP1689405A1 (de) 2006-08-16
WO2005046694A1 (en) 2005-05-26
EP1689405B1 (de) 2011-11-09
US8623864B2 (en) 2014-01-07
ES2377016T3 (es) 2012-03-21

Similar Documents

Publication Publication Date Title
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
DE60004374D1 (de) Zusammensetzung zur behandlung von infektionen bei mensch und tier
CL2004000234A1 (es) Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
BR112014031279A2 (pt) composições sinérgicas para a proteção de culturas agrícolas e o uso das mesmas
MX2015012760A (es) Composicion farmaceutica que comprende un activador de ampk y un agente serotonergico y metodos de uso de la misma.
DE60331537D1 (de) Kombinationen zur behandlung von multiplem myelom
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
WO2005014533A3 (en) Aryl and heteroaryl compounds, compositions, and methods of use
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
EA201070169A1 (ru) 2,3-дигидробензо[1,4]диоксин-2-илметиловые производные в качестве альфа2с антагонистов для применения в лечении заболеваний перифирической центральной нервной системы
BRPI0511527A (pt) compostos e composições como moduladores de ppar
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
CY1108196T1 (el) Αντιμικροβιακες φαρμακευτικες συνθεσεις χορηγουμενες απο το στομα
EP4272832A3 (de) Antimikrobielle verbindungen, zusammensetzungen sowie verwendungen davon
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
EA201690021A1 (ru) Алкалоидные композиции из вида ribes для лечения состояний, связанных с функцией митохондрий или ингибированием pde4, pde5 и ikk-бета
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
DE602007014206D1 (de) Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität
ATE522500T1 (de) Amidderivate als ionenkanalliganden sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür
ATE532517T1 (de) Thioridazin und seine derivate zur umkehr von antimikrobieller arzneimittelresistenz
ATE509018T1 (de) Als antimikrobielle mittel geeignete bisindolpyrrole
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей